Author

R. J. Monnat

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. D. Rodriguez· 2 shared A. Folch· 2 shared K. Castro· 2 shared L. F. Horowitz· 2 shared R. C. Rostomily· 2 shared W. Tang· 2 shared A. D. Mitchell· 1 shared A. G. Paulovich· 1 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. D. Rodriguez

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Cell BiologybioRxivMay 24, 2023

Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia

G. Qin, J. Dai, S. Chien…·P. S. Becker

The paper identifies mutation patterns linked to drug sensitivity in AML using integrated computational and experimental analysis.

DOI 10.1158/1078-0432.ccr-23-1674

humanwhole-exome sequencing

𝕏 PostBluesky

Cancer BiologybioRxivSep 11, 2022

Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource

H. T. Nguyen, W. Tang, A. L. H. Webster…·R. J. Monnat

The paper develops isogenic head and neck cancer cell line pairs to study Fanconi anemia-associated cancers and their treatment.

DOI 10.1002/ijc.34506

humanbulk RNA-seq

𝕏 PostBluesky

BioengineeringbioRxivMar 2, 2020

A Microfluidic Platform for Functional Testing of Cancer Drugs on Intact Tumor Slices

A. D. Rodriguez, L. F. Horowitz, K. Castro…·A. Folch

This paper develops a microfluidic platform for testing cancer drugs on intact tumor slices to improve drug response assessment in precision oncology.

DOI 10.1039/c9lc00811j

𝕏 PostBluesky

BioengineeringbioRxivFeb 25, 2020

Multiplexed drug testing of tumor slices using a microfluidic platform

L. F. Horowitz, A. D. Rodriguez, Z. Dereli-Korkut…·R. C. Rostomily

This paper develops a microfluidic platform for rapid, multiplexed drug testing of cancer slices to guide personalized therapy.

DOI 10.1038/s41698-020-0117-y

humanexperimental assay

𝕏 PostBluesky

Cell BiologybioRxivApr 30, 2018

An RNAi screen in human cell lines reveals conserved DNA damage repair pathways that mitigate formaldehyde sensitivity

E. Juarez, N. Chambwe, W. Tang…·A. McCullough

The paper identifies DNA damage repair pathways that reduce formaldehyde toxicity in human cell lines and shows their conservation in budding yeast.

DOI 10.1016/j.dnarep.2018.10.002

humanbulk RNA-seq

𝕏 PostBluesky